Wolverine Trading’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-28,500
Closed -$2.42M 5702
2019
Q4
$2.42M Sell
28,500
-29,000
-50% -$1.93M 0.01% 1683
2019
Q3
$2.77M Buy
+57,500
New +$2.29M 0.01% 1212
2019
Q2
Sell
-82,400
Closed -$2.3M 5481
2019
Q1
$2.3M Buy
82,400
+27,200
+49% +$641K 0.01% 1412
2018
Q4
$1.04M Sell
55,200
-4,100
-7% -$95.4K ﹤0.01% 1926
2018
Q3
$1.77M Buy
59,300
+51,600
+670% +$1.94M ﹤0.01% 1788
2018
Q2
$254K Hold
7,700
﹤0.01% 4030
2018
Q1
$254K Sell
7,700
-10,500
-58% -$328K ﹤0.01% 4030
2017
Q4
$498K Sell
18,200
-20,700
-53% -$638K ﹤0.01% 3002
2017
Q3
$1.44M Sell
38,900
-3,600
-8% -$133K 0.01% 1580
2017
Q2
$1.65M Sell
42,500
-34,300
-45% -$1.53M 0.01% 1364
2017
Q1
$3.77M Buy
76,800
+58,700
+324% +$2.68M 0.02% 797
2016
Q4
$614K Sell
18,100
-10,100
-36% -$358K ﹤0.01% 2388
2016
Q3
$1.07M Buy
28,200
+9,400
+50% +$354K 0.01% 1792
2016
Q2
$635K Buy
+18,800
New +$663K ﹤0.01% 1992

Other funds holding MDCO

Wolverine Trading's MDCO Position: Q1 2020 in Review

Wolverine Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 50,660 shares — an estimated $4.3M sold.

Wolverine Trading first reported a position in MDCO in Q2 2016 and held it in 9 quarters. The position peaked at $4.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Wolverine Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 50,660 Medicines Co shares in Q1 2020, an estimated $4.3M.
  • Wolverine Trading first reported a position in Medicines Co in Q2 2016 and held it in 9 quarters.
  • Wolverine Trading's Medicines Co position peaked at $4.3M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.